Beneficial Exposome Study of Essential Oils
This study, called the "Beneficial Exposome Study," is looking at how natural compounds might improve your health. Researchers want to understand the positive effects of regular exposure to Hinoki essential oil, Lemon essential oil, or plain water (as a control) diffused nightly for 4 weeks. They will measure your resting heart rate, heart rate variability (how your heart rate changes between beats), and sleep quality over 26 weeks to see if these compounds have a benefit. You can join if you are 18 or older, speak English, live in the US, and do not have certain medical conditions like epilepsy or allergies to the Cupressaceae plant family. The current recruitment status is unclear.
- Study design
- This interventional study plans to enroll 40 healthy participants. Participants will be assigned to use one of three different diffusers (Hinoki essential oil, Lemon essential oil, or water) each night.
- What's involved
- Participants will use a diffuser with their assigned compound every night for 4 weeks while they sleep. Measurements of heart rate and sleep quality will be taken at the beginning of the study and again at 26 weeks.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 26 weeks after the start of the study, with final measurements taken at that time.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Beneficial Exposome Study
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Michael Snyder, PhD · PRINCIPAL_INVESTIGATOR · Stanford University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Resting Heart RateBaseline; 26 weeks
Change in resting heart rate measured by wearable devices
- Heart Rate VariabilityBaseline; 26 weeks
Change in resting heart rate measured by wearable devices
- Change in sleep quality measured as duration of sleep stagesBaseline; 26 weeks
Duration of each sleep stage \[i.e. light, deep, rapid eye movement (REM), wake stages\] overnight. Sleep quality will be measured via a wearable device. Sleep quality will be compared to baseline through the other intervention phases.
- Profile of Mood StatesBaseline; weeks 2, 6, 10, 14, 18, 22, and 26
Change in mood states, a 65 item scale that allow for the quick assessment of transient, fluctuating feelings and enduring affect states.